RxSight, Inc. (RXST) — Operating Cash Flow
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$15.51M | +8.5% |
| 2024 | -$16.95M | +59.3% |
| 2023 | -$41.59M | +29.3% |
| 2022 | -$58.85M | -31.6% |
| 2021 | -$44.71M | -27.0% |
| 2020 | -$35.20M | — |
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$15.51M | +8.5% |
| 2024 | -$16.95M | +59.3% |
| 2023 | -$41.59M | +29.3% |
| 2022 | -$58.85M | -31.6% |
| 2021 | -$44.71M | -27.0% |
| 2020 | -$35.20M | — |